BTC Health Ltd Total Assets

Latest as of December 2025: AU$11.31 Million AUD ≈ $8.01 Million USD

BTC Health Ltd total assets. Based on the latest financial reports, BTC Health Ltd (BTC) holds total assets worth AU$11.31 Million AUD (≈ $8.01 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see BTC Health Ltd stock valuation for the company's overall valuation and market capitalisation.

Total Assets of BTC Health Ltd (2000–2025)

Total assets of BTC Health Ltd from 2000 to 2025. This chart illustrates how BTC Health Ltd's total assets have evolved over time, based on quarterly financial data. See BTC live share price for real-time trading data and today's change.

BTC Health Ltd - Asset Composition Analysis

BTC Health Ltd Total Assets Breakdown (June 2025)

BTC Health Ltd total assets breakdown as of June 2025. BTC Health Ltd's total assets of AU$11.31 Million consist of 6.8% current assets and 93.2% non-current assets.

Asset Category Amount (AUD) % of Total Assets
Cash & Equivalents AU$620.11K 6.6%
Accounts Receivable AU$0.00 0.0%
Inventory AU$0.00 0.0%
Property, Plant & Equipment AU$0.00 0.0%
Intangible Assets AU$0.00 0.0%
Goodwill AU$0.00 0.0%

Asset Composition Trend (2000–2025)

This chart illustrates how BTC Health Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore BTC working capital efficiency to assess how much short-term liquidity the company maintains relative to its equity base.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: BTC Health Ltd's current assets represent 6.8% of total assets in 2025, a decrease from 100.0% in 2000.
  • Cash Position: Cash and equivalents constituted 6.6% of total assets in 2025, down from 100.0% in 2000.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2000.
  • Asset Diversification: The largest asset category is cash and equivalents at 6.6% of total assets.

BTC Health Ltd Competitors by Total Assets

Key competitors of BTC Health Ltd based on total assets are shown below.

Company Country Total Assets
Xizang Haisco Pharmaceutical Group Co Ltd
SHE:002653
China CN¥7.88 Billion
Halozyme Therapeutics Inc
NASDAQ:HALO
USA $2.22 Billion
Shanghai RAAS Blood Products Co Ltd Class A
SHE:002252
China CN¥37.46 Billion
Definium Therapeutics, Inc.
NASDAQ:DFTX
USA $1.11 Billion
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SHG:603392
China CN¥13.71 Billion
BB Biotech AG
SW:BION
Switzerland CHF3.09 Billion
Zealand Pharma A/S
CO:ZEAL
Denmark Dkr16.46 Billion
Xiamen Amoytop Biotech Co Ltd
SHG:688278
China CN¥3.21 Billion

BTC Health Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 22.45 3.75 13.59
Quick Ratio 22.45 3.75 13.59
Cash Ratio 22.45 3.44 13.47
Working Capital AU$1.57 Million AU$635.57K AU$2.16 Million

BTC Health Ltd - Advanced Valuation Insights

This section examines the relationship between BTC Health Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 1.74
Latest Market Cap to Assets Ratio 1.30
Asset Growth Rate (YoY) 81.8%
Total Assets AU$9.36 Million
Market Capitalization $12.14 Million USD

Valuation Analysis

Above Book Valuation: The market values BTC Health Ltd's assets above their book value (1.30x), reflecting positive investor sentiment about the company's future prospects.

Rapid Asset Growth: BTC Health Ltd's assets grew by 81.8% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for BTC Health Ltd (2000–2025)

The table below shows the annual total assets of BTC Health Ltd from 2000 to 2025.

Year Total Assets Change
2025-06-30 AU$9.36 Million
≈ $6.62 Million
+81.76%
2024-06-30 AU$5.15 Million
≈ $3.64 Million
+75.03%
2023-06-30 AU$2.94 Million
≈ $2.08 Million
-77.40%
2022-06-30 AU$13.02 Million
≈ $9.21 Million
+0.26%
2021-06-30 AU$12.98 Million
≈ $9.19 Million
+13.33%
2020-06-30 AU$11.46 Million
≈ $8.11 Million
-2.24%
2019-06-30 AU$11.72 Million
≈ $8.29 Million
+253.48%
2018-06-30 AU$3.32 Million
≈ $2.35 Million
-28.96%
2017-06-30 AU$4.67 Million
≈ $3.30 Million
+72.41%
2016-06-30 AU$2.71 Million
≈ $1.92 Million
+156.85%
2015-06-30 AU$1.05 Million
≈ $745.76K
-17.97%
2014-06-30 AU$1.28 Million
≈ $909.13K
-59.45%
2013-06-30 AU$3.17 Million
≈ $2.24 Million
-35.71%
2012-06-30 AU$4.93 Million
≈ $3.49 Million
-58.05%
2011-06-30 AU$11.75 Million
≈ $8.31 Million
-27.20%
2010-06-30 AU$16.14 Million
≈ $11.42 Million
-31.18%
2009-06-30 AU$23.45 Million
≈ $16.59 Million
-16.66%
2008-06-30 AU$28.14 Million
≈ $19.91 Million
-25.87%
2007-06-30 AU$37.96 Million
≈ $26.86 Million
-20.81%
2006-06-30 AU$47.93 Million
≈ $33.91 Million
+12.95%
2005-06-30 AU$42.44 Million
≈ $30.03 Million
-12.14%
2004-06-30 AU$48.30 Million
≈ $34.18 Million
+22.69%
2003-06-30 AU$39.37 Million
≈ $27.86 Million
-0.02%
2002-06-30 AU$39.38 Million
≈ $27.86 Million
-1.79%
2001-06-30 AU$40.10 Million
≈ $28.37 Million
+0.12%
2000-06-30 AU$40.05 Million
≈ $28.34 Million
--

About BTC Health Ltd

AU:BTC Australia Biotechnology
Market Cap
$12.14 Million
AU$17.16 Million AUD
Market Cap Rank
#26424 Global
#1191 in Australia
Share Price
AU$0.05
Change (1 day)
+0.00%
52-Week Range
AU$0.05 - AU$0.07
All Time High
AU$0.24
About

BTC Health Limited is a Pooled Development Fund managed by LHC Capital Partners Pty Ltd specializing in seed/startup, early venture, mid venture, late venture, emerging growth and growth capital investments. It makes investments in the healthcare, acute pain management, neuro-spinal, cardiovascular, pharmaceutical, medical technologies, biotechnology sector with a focus on post-genomics, stem cel… Read more